Clinical Trials Browser

orludodstat × Clear all

NCT03404726 2022-01-11

A Study to Investigate BAY2402234, a Dihydroorotate Dehydrogenase (DHODH) Inhibitor, in Myeloid Malignancies

Phase 1 Terminated

MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT05061251 2022-01-11

Surgical Window of Opportunity Study of Orally Administered BAY 2402234 in Recurrent Glioma

Phase EARLY_PHASE1 Withdrawn

Glioma